ecancermedicalscience

Conference Report

Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials

8 Dec 2014
Linda Cairns

Chemoprevention or the now more preferred ‘cancer prevention’ is the long-term administration of a biological or chemical agent to reduce the risk of cancer. This approach has long been active in individuals at high risk of developing breast or colon cancer. The aim of this expert meeting was to review the current status of the field of cancer prevention and potential, emerging biomarkers specifically focusing on breast, colon, and lung cancer but also with sessions on ovary and prostate.

Related Articles

Julia Palma, Sofía Aljaro, Daniela Arce, Milena Villarroel, Federico Antillón, Luiz Lopes, Nataly Mercado, Adriana Morais, Andrés Portilla, Leonardo Arana, Guillermo Chantada, Mónica Cypriano, Soad Fuentes, Augusto Pereira, Lourdes Vega, Nubia Zuñiga, Liliana Vásquez, Andrea Capellano, Paola Friedrich
Carolina Muñoz Olivar, Sylvia Ramis, Francisco Acevedo, Benjamin Walbaum, Karol Ramirez, Gina Merino, Barbara Samith, Isabel Saffie, Carolina Zarate, Lidia Medina, Constanza Figueroa, Francisco Dominguez, Mauricio Camus, Catalina Vargas, Maria Elena Navarro, Dravna Razmilic, Marisel Navarro, Constanza Pinto, Catalina Muñoz, Raul Martinez, Manuel Manzor, Cesar Sanchez
Ariel Cherro, Laura Aresca, María Susana Ciruzzi, Alejo Agranatti, María Fernanda Montaña, Cynthia Frahne, Jaqueline Cimerman
Grace M Ferri*, John F Murphy*, Akash Oza*, Alexander J B Bulteel, Wafaa Abbasi, Rachel Anderson, Mehmed Taha Dinc, Eva Gaufberg, Kayra Cengiz, Sainikhil Sontha, Janice Weinberg, Patrick Kurpaska, Yashvin Onkarappa Mangala, Matthew Kulke, Umit Tapan
Meghal Prajapati, Anil Kumar Goel, Yamini Patel, Divyeshkumar Rana, S Lokesh, Pooja Panchal, Dhruv Rathod, Chandramouli Ramalingam, Kondeti Ajay Kumar